Skip to main content

Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD
0.3599
+0.0147 (4.26%)
May 14, 2025, 10:24 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Novel Immunotherapies
7.88M
Log In
Log In
Log In
Log In
Novel Immunotherapies Growth
37.48%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
7.88M
Log In
Log In
Log In
Log In
United States Growth
37.48%
Log In
Log In
Log In
Log In